微创青光眼手术进展  

Recent advances on micro-invasive glaucom a surgery

作　　者：左国进[1] 张祖海[1] 

机构地区：[1]长江大学附属第一医院眼科,中国湖北省荆州市434000

出　　处：《国际眼科杂志》2017年第2期251-253,共3页International Eye Science

摘　　要：青光眼是继白内障之后致盲的第二个主要原因。传统的小梁切除术和分流器植入术仍然是治疗青光眼最常见的手术方式。然而,这些治疗的局限性在于安全性和失败率。微创青光眼手术(micro invasive glaucoma surgery,MIGS)是新兴出现的一类青光眼手术,相对于传统的青光眼手术而言,具有五个特点:(1)一个内部的微小切口;(2)创伤小;(3)疗效确切;(4)安全性高;(5)恢复快,此外,还可以减少术后抗青光眼药物的使用。该类手术可以在3个不同的空间进行:Schlemm管、脉络膜上腔、结膜下腔。现将微创青光眼手术做一综述。Glaucoma is the second major causes of blindness after cataract.The conventional trabeculectomy and shunt implantation is still the most common surgical procedure in treatment of glaucoma.However,the limitations of the treatments are the security and failure rate.Micro-invasive glaucoma surgery（MIGS） is an emerging category which shares the following five characteristics compared with traditional glaucoma surgery：（1） an interno microincision,（2） micro-invasion,（3） definite curative effect,（4） high safety,and（5） rapid recovery,moreover,it can also reduce the use of glaucoma medication after operation.This kind of surgery can be conducted in three different space,such as Schlemm canal,the suprachoroidal space,and the subconjunctival space.This article reviews briefly the new techniques of micro-invasive glaucoma surgery.

关 键 词：微创 青光眼手术 眼压 

分 类 号：R779.6[医药卫生—眼科]